These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38834085)

  • 41. Impact of inappropriate antimicrobial therapy on outcome in patients with hospital-acquired pneumonia caused by Acinetobacter baumannii.
    Joung MK; Kwon KT; Kang CI; Cheong HS; Rhee JY; Jung DS; Chung SM; Lee JA; Moon SY; Ko KS; Chung DR; Lee NY; Song JH; Peck KR
    J Infect; 2010 Sep; 61(3):212-8. PubMed ID: 20600295
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of pandemic influenza (H1N1) virus-associated community-acquired pneumonia among adults in a tertiary hospital in Thailand.
    Champunot R; Tanjatham S; Kerdsin A; Puangpatra P; Wangsai S; Treebuphachatsakul P; Tasnsuphaswasdikul S; Kiatvitchukul C; Kasyanan H; Yimsabai J; Akeda Y; Kawakami K; Sawanpanyalert P; Dejsirilert S; Oishi K
    Jpn J Infect Dis; 2010 Jul; 63(4):251-6. PubMed ID: 20657064
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular Epidemiology and Drug Resistance of Acinetobacter baumannii Isolated from Hospitals in Southern Poland: ICU as a Risk Factor for XDR Strains.
    Chmielarczyk A; Pilarczyk-Żurek M; Kamińska W; Pobiega M; Romaniszyn D; Ziółkowski G; Wójkowska-Mach J; Bulanda M
    Microb Drug Resist; 2016 Jun; 22(4):328-35. PubMed ID: 26745326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early administration of appropriate antimicrobial agents to improve the outcome of carbapenem-resistant Acinetobacter baumannii complex bacteraemic pneumonia.
    Park SY; Lee EJ; Kim T; Yu SN; Park KH; Lee MS; Park SY; Jeon MH; Kim TH; Choo EJ
    Int J Antimicrob Agents; 2018 Mar; 51(3):407-412. PubMed ID: 29122697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk Factors, Clinical Presentation, and Outcome of
    Ballouz T; Aridi J; Afif C; Irani J; Lakis C; Nasreddine R; Azar E
    Front Cell Infect Microbiol; 2017; 7():156. PubMed ID: 28523249
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa - an update.
    Lowings M; Ehlers MM; Dreyer AW; Kock MM
    BMC Infect Dis; 2015 Nov; 15():521. PubMed ID: 26573617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Characterization and determination of antibiotic resistance profiles of a single clone Acinetobacter baumannii strains isolated from blood cultures].
    Karagöz A; Baran I; Aksu N; Acar S; Durmaz R
    Mikrobiyol Bul; 2014 Oct; 48(4):566-76. PubMed ID: 25492652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Severe community-acquired pneumonia (CAP) treated at Srinagarind Hospital, Khon Kaen, Thailand.
    Reechaipichitkul W; Pisprasert V
    Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):430-3. PubMed ID: 15691151
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Analysis of clinical characteristics and antimicrobial resistance of carbapenem-resistant Acinetobacter baumannii infections in children].
    Zhang TQ; Dong L; Wang ZY; Li HY
    Zhonghua Er Ke Za Zhi; 2011 Jul; 49(7):545-9. PubMed ID: 22088187
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diversity of Acinetobacter baumannii strains isolated in humans, companion animals, and the environment in Reunion Island: an exploratory study.
    Pailhoriès H; Belmonte O; Kempf M; Lemarié C; Cuziat J; Quinqueneau C; Ramont C; Joly-Guillou ML; Eveillard M
    Int J Infect Dis; 2015 Aug; 37():64-9. PubMed ID: 26093214
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular and epidemiological investigation of a colistin-resistant OXA-23-/NDM-1-producing Acinetobacter baumannii outbreak in the Southwest Indian Ocean Area.
    Miltgen G; Bour M; Allyn J; Allou N; Vedani T; Vuillemenot JB; Triponney P; Martinet O; Lugagne N; Benoit-Cattin T; Dortet L; Birer A; Jaffar-Bandjee MC; Belmonte O; Plésiat P; Potron A
    Int J Antimicrob Agents; 2021 Oct; 58(4):106402. PubMed ID: 34293453
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings.
    Garnacho-Montero J; Ortiz-Leyba C; Fernández-Hinojosa E; Aldabó-Pallás T; Cayuela A; Marquez-Vácaro JA; Garcia-Curiel A; Jiménez-Jiménez FJ
    Intensive Care Med; 2005 May; 31(5):649-55. PubMed ID: 15785929
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sputum bacteriology and antibiotic sensitivity patterns of community-acquired pneumonia in hospitalized adult patients in Nigeria: a 5-year multicentre retrospective study.
    Iroezindu MO; Chima EI; Isiguzo GC; Mbata GC; Onyedum CC; Onyedibe KI; Okoli LE
    Scand J Infect Dis; 2014 Dec; 46(12):875-87. PubMed ID: 25288384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibiotic resistance in community-acquired pneumonia caused by Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus, and Acinetobacter baumannii.
    Ho PL; Cheng VC; Chu CM
    Chest; 2009 Oct; 136(4):1119-1127. PubMed ID: 19809053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acinetobacter baumannii nosocomial pneumonia: is the outcome more favorable in non-ventilated than ventilated patients?
    Yang YS; Lee YT; Huang TW; Sun JR; Kuo SC; Yang CH; Chen TL; Lin JC; Fung CP; Chang FY
    BMC Infect Dis; 2013 Mar; 13():142. PubMed ID: 23509931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical characteristics and outcomes of community and hospital-acquired Acinetobacter baumannii bacteremia.
    Chusri S; Chongsuvivatwong V; Silpapojakul K; Singkhamanan K; Hortiwakul T; Charernmak B; Doi Y
    J Microbiol Immunol Infect; 2019 Oct; 52(5):796-806. PubMed ID: 31031096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bacteremic community-acquired pneumonia due to Klebsiella pneumoniae: clinical and microbiological characteristics in Taiwan, 2001-2008.
    Lin YT; Jeng YY; Chen TL; Fung CP
    BMC Infect Dis; 2010 Oct; 10():307. PubMed ID: 20973971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors of mortality in patients with extensively drug-resistant Acinetobacter baumannii pneumonia receiving colistin therapy.
    Choi IS; Lee YJ; Wi YM; Kwan BS; Jung KH; Hong WP; Kim JM
    Int J Antimicrob Agents; 2016 Aug; 48(2):175-80. PubMed ID: 27423416
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups.
    Anstey NM; Currie BJ; Hassell M; Palmer D; Dwyer B; Seifert H
    J Clin Microbiol; 2002 Feb; 40(2):685-6. PubMed ID: 11825997
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk factors.
    Dizbay M; Tunccan OG; Sezer BE; Hizel K
    Scand J Infect Dis; 2010 Oct; 42(10):741-6. PubMed ID: 20500117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.